1. New Products

New Products

Cat. No. Product Name Target Research Area Added Chemical Structure
HY-10449 Luseogliflozin

SGLT

Metabolic Disease

Jul-2018 Luseogliflozin
HY-15861 Targapremir-210

MicroRNA

Cancer

Jul-2018 Targapremir-210
HY-105218 Ifetroban

Prostaglandin Receptor

Cardiovascular Disease

Jul-2018 Ifetroban
HY-105283 PF 04531083

Sodium Channel

Neurological Disease

Jul-2018 PF 04531083
HY-15873 FTI 276

Farnesyl Transferase

Cancer

Jul-2018 FTI 276
HY-105185 Fidarestat

Aldose Reductase

Metabolic Disease

Jul-2018 Fidarestat
HY-10416 Oxamniquine

Parasite

Infection

Jul-2018 Oxamniquine
HY-105018 GSK 557296

Oxytocin Receptor

Others

Jul-2018 GSK 557296
HY-101395 W146

LPL Receptor

Cancer;

Metabolic Disease

Jul-2018 W146
HY-104015 NecroX-5

Calcium Channel

Cancer;

Inflammation/Immunology

Jul-2018 NecroX-5
HY-100685 MS-444

Myosin

Cancer

Jul-2018 MS-444
HY-104022 CHK1 inhibitor

Checkpoint Kinase (Chk)

Others

Jul-2018 CHK1 inhibitor
HY-104012 MK-8591

HIV; Reverse Transcriptase

Infection

Jul-2018 MK-8591
HY-104071 Succinaldehydic acid

Others

Others

Jul-2018 Succinaldehydic acid
HY-104070 LG-100064

RAR/RXR

Cancer

Jul-2018 LG-100064
HY-111381 BI-3812

Others

Cancer

Jul-2018 BI-3812
HY-104077 Remdesivir

SARS-CoV

Infection

Jul-2018 Remdesivir
HY-15790 Elobixibat

Others

Metabolic Disease

Jul-2018 Elobixibat
HY-103315 Bepridil hydrochloride

Calcium Channel

Cardiovascular Disease

Jul-2018 Bepridil hydrochloride
HY-104051 Monacolin J

HMG-CoA Reductase (HMGCR)

Metabolic Disease

Jul-2018 Monacolin J